Company Filing History:
2 out of 34 
1 out of 900 
1 out of 53 
Years Active: 2003-2008
Title: The Innovations of Jin-Wan Kim
Introduction
Jin-Wan Kim is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that enhance kinase activity. With a total of four patents to his name, his work has the potential to impact the treatment of serious health conditions.
Latest Patents
One of Jin-Wan Kim's latest patents involves the creation of 4,5,6,7-tetrahydro-[1,2]dithiolo[4,3-C] pyridine-3-thione compounds. This invention relates to new compounds that directly increase the kinase activity of p90 ribosomal S6 kinase 1 (RSK1). The pharmaceutical composition comprising these compounds serves as an active ingredient for preventing or treating hepatic fibrosis or cirrhosis. Additionally, he has developed a method for administering a therapeutically effective amount of this composition to mammals. Another significant patent is a processing method for lactonization in the preparation of statins. This method allows for the production of lovastatin and simvastatin with high purity and yield, while also reducing the formation of heterodimers as by-products.
Career Highlights
Throughout his career, Jin-Wan Kim has worked with prominent companies such as Cheiljedang Corp. and CJ Cheiljedang Corporation. His experience in these organizations has contributed to his expertise in pharmaceutical innovations and processing methods.
Collaborations
Jin-Wan Kim has collaborated with notable coworkers, including Kwang-Do Choi and Sang-Ho Lee. Their combined efforts have likely enhanced the quality and impact of their research and inventions.
Conclusion
Jin-Wan Kim's contributions to the field of pharmaceuticals through his innovative patents demonstrate his commitment to advancing medical science. His work has the potential to significantly improve treatment options for various health conditions.